What does Dr. Roelandts Lieven - Huisarts do?

Dr. Roelandts Lieven - Huisarts is a general practice in Rumst. Private Limited, started on 21 November 2018, 2 establishments.

What is the address of Dr. Roelandts Lieven - Huisarts?

The registered office of Dr. Roelandts Lieven - Huisarts is located at Monnikenhofstraat 6, 2840 Rumst.

Is Dr. Roelandts Lieven - Huisarts still active?

Yes. According to the CBE (25 September 2026) Dr. Roelandts Lieven - Huisarts is active, legal situation “Normale toestand”, started on 21 November 2018.

Is Dr. Roelandts Lieven - Huisarts registered on Peppol?

Yes, Dr. Roelandts Lieven - Huisarts is registered on the Peppol network with ID 0208:0713754011.

What is the enterprise number of Dr. Roelandts Lieven - Huisarts?

The enterprise number of Dr. Roelandts Lieven - Huisarts is BE0713754011.

When was Dr. Roelandts Lieven - Huisarts founded?

Dr. Roelandts Lieven - Huisarts was founded on 21 November 2018.

Who are the directors of Dr. Roelandts Lieven - Huisarts?

According to the 2025 annual accounts, the directors of Dr. Roelandts Lieven - Huisarts are: Lieven Roelandts.

Is Dr. Roelandts Lieven - Huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 November 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. Roelandts Lieven - Huisarts make in 2025?

Dr. Roelandts Lieven - Huisarts posted a profit after taxes of € 76,059 in financial year 2025.

What is the revenue of Dr. Roelandts Lieven - Huisarts?

As a small company, Dr. Roelandts Lieven - Huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 172,256.

Dr. Roelandts Lieven - Huisarts (Private Limited) - Rumst

Dossier Dr. Roelandts Lieven - Huisarts, printed on 25 September 2026 from databakkes.be/en/0713754011/dr-roelandts-lieven-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Roelandts Lieven - Huisarts from Rumst, company number BE0713754011, closed financial year 2025 with a result of € 76,059 after tax. For that financial year Dr. Roelandts Lieven - Huisarts recorded a gross margin of € 172,256 and equity of € 347,495. Compared with financial year 2024, the result moved from € 109,660 to € 76,059. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 347,495

▼ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 76,059

▼ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,518

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 159,115 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 87,392

▼ 39% vs 2024

€ 59,010 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 3,141

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 172,143 Gross margin 2022: € 172,143 First fiscal year in the series	€ 144,847 Gross margin 2023: € 144,847 ▼ 16% vs 2022 (€ 172,143) Unfavourable step	€ 215,440 Gross margin 2024: € 215,440 ▲ 49% vs 2023 (€ 144,847) Favourable step	€ 172,256 Gross margin 2025: € 172,256 ▼ 20% vs 2024 (€ 215,440) Unfavourable step	▼ 20%
Profit after taxes	€ 77,952 Profit after taxes 2022: € 77,952 First fiscal year in the series	€ 61,424 Profit after taxes 2023: € 61,424 ▼ 21% vs 2022 (€ 77,952) Unfavourable step	€ 109,660 Profit after taxes 2024: € 109,660 ▲ 79% vs 2023 (€ 61,424) Favourable step	€ 76,059 Profit after taxes 2025: € 76,059 ▼ 31% vs 2024 (€ 109,660) Unfavourable step	▼ 31%
Equity	€ 259,467 Equity 2022: € 259,467 First fiscal year in the series	€ 320,891 Equity 2023: € 320,891 ▲ 24% vs 2022 (€ 259,467) Favourable step	€ 430,551 Equity 2024: € 430,551 ▲ 34% vs 2023 (€ 320,891) Favourable step	€ 347,495 Equity 2025: € 347,495 ▼ 19% vs 2024 (€ 430,551) Unfavourable step	▼ 19%
Total debts	€ 287,844 Total debts 2022: € 287,844 First fiscal year in the series	€ 269,407 Total debts 2023: € 269,407 ▼ 6% vs 2022 (€ 287,844) Favourable step	€ 162,693 Total debts 2024: € 162,693 ▼ 40% vs 2023 (€ 269,407) Favourable step	€ 168,410 Total debts 2025: € 168,410 ▲ 4% vs 2024 (€ 162,693) Unfavourable step	▲ 4%
Cash	€ 112,200 Cash 2022: € 112,200 First fiscal year in the series	€ 64,025 Cash 2023: € 64,025 ▼ 43% vs 2022 (€ 112,200) Unfavourable step	€ 10,656 Cash 2024: € 10,656 ▼ 83% vs 2023 (€ 64,025) Unfavourable step	€ 10,518 Cash 2025: € 10,518 ▼ 1% vs 2024 (€ 10,656) Unfavourable step	▼ 1%
Land & buildings	€ 152,960 Land & buildings 2022: € 152,960 First fiscal year in the series	€ 143,400 Land & buildings 2023: € 143,400 ▼ 6% vs 2022 (€ 152,960) Unchanged	€ 133,840 Land & buildings 2024: € 133,840 ▼ 7% vs 2023 (€ 143,400) Unchanged	€ 124,280 Land & buildings 2025: € 124,280 ▼ 7% vs 2024 (€ 133,840) Unchanged	▼ 7%
Retained profit	€ 247,067 Retained profit 2022: € 247,067 First fiscal year in the series	€ 308,491 Retained profit 2023: € 308,491 ▲ 25% vs 2022 (€ 247,067) Favourable step	€ 418,151 Retained profit 2024: € 418,151 ▲ 36% vs 2023 (€ 308,491) Favourable step	€ 335,095 Retained profit 2025: € 335,095 ▼ 20% vs 2024 (€ 418,151) Unfavourable step	▼ 20%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 159,115 Dividend 2025: € 159,115 Unchanged (€ 0) Unchanged
Bank debt	€ 261,960 Bank debt 2022: € 261,960 First fiscal year in the series	€ 253,409 Bank debt 2023: € 253,409 ▼ 3% vs 2022 (€ 261,960) Favourable step	€ 143,586 Bank debt 2024: € 143,586 ▼ 43% vs 2023 (€ 253,409) Favourable step	€ 87,392 Bank debt 2025: € 87,392 ▼ 39% vs 2024 (€ 143,586) Favourable step	▼ 39%
Balance sheet total	€ 547,312 Balance sheet total 2022: € 547,312 First fiscal year in the series	€ 590,298 Balance sheet total 2023: € 590,298 ▲ 8% vs 2022 (€ 547,312) Unchanged	€ 593,244 Balance sheet total 2024: € 593,244 Unchanged (€ 590,298) Unchanged	€ 515,904 Balance sheet total 2025: € 515,904 ▼ 13% vs 2024 (€ 593,244) Unchanged	▼ 13%

Key figures of Dr. Roelandts Lieven - Huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Roelandts Lieven - Huisarts?

What happened at Dr. Roelandts Lieven - Huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 76,059 (▼ 31% vs 2024). Source: NBB ↗
Jan 2, 2019 New establishment in Boom. KBO
Nov 21, 2018 New establishment in Rumst. KBO
Nov 21, 2018 Start of the company according to the CBE. KBO

In short

From € 77,952 profit in 2022 to € 76,059 profit in 2025.

Paid € 139,230 in corporate taxes since 2022.

Best year ever: 2024, with € 109,660 profit.

Paid out € 159,115 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Roelandts Lieven - Huisarts? We notify you, reason included.

Follow Dr. Roelandts Lieven - Huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit